These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
442 related items for PubMed ID: 27862987
1. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany. Schmitt J, Abraham S, Trautmann F, Stephan V, Fölster-Holst R, Homey B, Bieber T, Novak N, Sticherling M, Augustin M, Kleinheinz A, Elsner P, Weidinger S, Werfel T. J Dtsch Dermatol Ges; 2017 Jan; 15(1):49-59. PubMed ID: 27862987 [Abstract] [Full Text] [Related]
2. [Decreased professional performance and quality of life in patients with moderate-to-severe atopic eczema : Results from the German atopic eczema registry TREATgermany]. Haufe E, Abraham S, Heratizadeh A, Harder I, Zink A, Weisshaar E, Kleinheinz A, von Kiedrowski R, Worm M, Bell M, Wollenberg A, Neubert K, Staubach-Renz P, Hilgers M, Bieber T, Fell I, Homey B, Effendy I, Mempel M, Schäkel K, Beissert S, Weidinger S, Werfel T, Schmitt J. Hautarzt; 2018 Oct; 69(10):815-824. PubMed ID: 30191254 [Abstract] [Full Text] [Related]
3. Baseline characteristics, disease severity and treatment history of patients with atopic dermatitis included in the German AD Registry TREATgermany. Heratizadeh A, Haufe E, Stölzl D, Abraham S, Heinrich L, Kleinheinz A, Wollenberg A, Weisshaar E, Augustin M, Wiemers F, Zink A, von Kiedrowski R, Hilgers M, Worm M, Pawlak M, Sticherling M, Fell I, Handrick C, Schäkel K, Staubach-Renz P, Asmussen A, Schwarz B, Bell M, Effendy I, Bieber T, Homey B, Gerlach B, Tchitcherina E, Stahl M, Schwichtenberg U, Rossbacher J, Buck P, Mempel M, Beissert S, Biedermann T, Weidinger S, Schmitt J, Werfel T, TREATgermany Study Group. J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1263-1272. PubMed ID: 31721316 [Abstract] [Full Text] [Related]
5. Itching in Atopic Dermatitis: Patient- and Physician-reported Outcomes in the German Atopic Dermatitis Registry TREATgermany. Weisshaar E, Bentz P, Apfelbacher C, Haufe E, Heinrich L, Heratizadeh A, Abraham S, Harder I, Kleinheinz A, Wollenberg A, Schäkel K, Wiemers F, Ertner J, Augustin M, Wildberger J, Von Kiedrowski R, Worm M, Zink A, Effendy I, Asmussen A, Pawlak M, Sticherling M, Hilgers M, Handrick C, Quist S, Schwarz B, Bell M, Staubach-Renz P, Hong-Weldemann SH, Homey B, Brücher JJ, Weidinger S, Werfel T, Schmitt J, TREATgermany study group. Acta Derm Venereol; 2023 Jan 23; 103():adv00854. PubMed ID: 36688701 [Abstract] [Full Text] [Related]
8. Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis. Drucker AM, Ellis AG, Bohdanowicz M, Mashayekhi S, Yiu ZZN, Rochwerg B, Di Giorgio S, Arents BWM, Burton T, Spuls PI, Küster D, Siegels D, Schmitt J, Flohr C. JAMA Dermatol; 2020 Jun 01; 156(6):659-667. PubMed ID: 32320001 [Abstract] [Full Text] [Related]
9. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey. Totri CR, Eichenfield LF, Logan K, Proudfoot L, Schmitt J, Lara-Corrales I, Sugarman J, Tom W, Siegfried E, Cordoro K, Paller AS, Flohr C. J Am Acad Dermatol; 2017 Feb 01; 76(2):281-285. PubMed ID: 27855965 [Abstract] [Full Text] [Related]
11. A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT). Irvine AD, Jones AP, Beattie P, Baron S, Browne F, Ashoor F, O'Neill L, Rosala-Hallas A, Sach T, Spowart C, Taams L, Walker C, Wan M, Webb N, Williamson P, Flohr C, TREAT Trial InvestigatorsUnit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, U.K.. Br J Dermatol; 2018 Dec 01; 179(6):1297-1306. PubMed ID: 29727479 [Abstract] [Full Text] [Related]
12. Clinical phenotypes of adult atopic dermatitis and related therapies. Patruno C, Potestio L, Napolitano M. Curr Opin Allergy Clin Immunol; 2022 Aug 01; 22(4):242-249. PubMed ID: 35786802 [Abstract] [Full Text] [Related]
13. Systemic anti-inflammatory treatment of atopic dermatitis during conception, pregnancy and breastfeeding: Interdisciplinary expert consensus in Northern Europe. Deleuran M, Dézfoulian B, Elberling J, Knutar I, Lapeere H, Lossius AH, Schuttelaar MLA, Stockman A, Wikström E, Bradley M, de Bruin-Weller M, Gutermuth J, Mandelin JM, Schmidt MC, Thyssen JP, Vestergaard C. J Eur Acad Dermatol Venereol; 2024 Jan 01; 38(1):31-41. PubMed ID: 37818828 [Abstract] [Full Text] [Related]
17. Status report on the atopic dermatitis registry TREATgermany. Siegels D, Haufe E, Heinrich L, Werfel T, Weidinger S, Schmitt J, TREATgermany Study Group. Allergol Select; 2021 Jan 01; 5():274-286. PubMed ID: 34532636 [Abstract] [Full Text] [Related]
18. [Current and upcoming treatments of adult atopic dermatitis]. Lacour JP. Ann Dermatol Venereol; 2017 Dec 01; 144 Suppl 5():VS29-VS37. PubMed ID: 29433635 [Abstract] [Full Text] [Related]
19. Definition of treatment goals in terms of clinician-reported disease severity and patient-reported outcomes in moderate-to-severe adult atopic dermatitis: a systematic review. Iannone M, Tonini G, Janowska A, Dini V, Romanelli M. Curr Med Res Opin; 2021 Aug 01; 37(8):1295-1301. PubMed ID: 34027753 [Abstract] [Full Text] [Related]
20. Adverse event monitoring in patients on oral systemic medications for inflammatory skin disease. Singh P, Silverberg JI. J Am Acad Dermatol; 2020 Jun 01; 82(6):1537-1539. PubMed ID: 32088273 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]